

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

As the International Day Against Drug Abuse and Illicit Trafficking approaches on June 26, the Anti-Death Penalty Asia Network (ADPAN), of which Amnesty International is a member, Human Rights Watch and the International Harm Reduction Association call upon governments in Asia to cease applying the death penalty for drug-related offenses.
There is a clear, longstanding and worldwide move toward restriction or abolition of the death penalty. Only a small minority of countries continue to implement the death penalty: in 2008, 25 countries carried out executions. ADPAN, Human Rights Watch and the International Harm Reduction Association (IHRA) oppose the death penalty in all cases as a violation of fundamental rights - the right to life and the right not to be subjected to cruel, inhuman, and degrading punishment.
Sixteen countries in Asia apply the death penalty for drug-related offenses. As many countries in the region do not make information on the death penalty available, it is impossible to calculate exactly how many drug-related death sentences are imposed. However, in Indonesia, Malaysia, Singapore, and Thailand, reports indicate that a high proportion of death sentences are imposed upon those convicted of drug offenses. ADPAN, Human Rights Watch, and the IHRA express particular concern that China, Indonesia, and Vietnam continue to execute individuals for drug offenses - and that some countries, such as China since the early 1990s, and Indonesia in 2008, have marked the occasion of June 26 with such executions.
Despite the executions in Asia, there is no clear evidence of a decline in drug-trafficking that could be attributed to the threat or use of the death penalty. There is no credible evidence that the death penalty deters serious crime in general more effectively than other punishments. The most recent survey of research findings on the relation between the death penalty and homicide rates, conducted for the United Nations in 1988 and updated in 1996 and 2002, concluded: "... research has failed to provide scientific proof that executions have a greater deterrent effect than life imprisonment. Such proof is unlikely to be forthcoming. The evidence as a whole gives no positive support to the deterrent hypothesis."
UN human rights mechanisms - including the UN special rapporteur on extrajudicial, summary, or arbitrary executions, and the UN Human Rights Committee - have concluded that the death penalty for drug offenses fails to meet the condition of "most serious crime", under which the death penalty is allowed only as an "exceptional measure" where "there was an intention to kill which resulted in the loss of life" (UN Doc, A/HRC/4/20, 29 January 2007, para 53). The UN high commissioner for human rights and the director of the UN Office on Drugs and Crime have likewise expressed grave concerns about the application of the death penalty for drug offenses.
Death sentences are often handed down after unfair legal processes, a problem made worse by laws, policies or practices regulating drug offenses in some Asian countries. Mandatory death sentences are applied for certain drug offenses in Brunei, India, Laos, Singapore, and Malaysia, leaving a judge with no discretion over the sentence for defendants found guilty. Mandatory death sentences violate international standards on fair trials. Individualized sentencing is required to prevent cruel, inhuman, or degrading punishment and the arbitrary deprivation of life. Singapore, which has one of the highest per capita execution rates in the world, as well as Malaysia, continue to hand down death sentences to individuals alleged to be drug traffickers after trials that presume guilt, and in which death sentences are mandatory.
Confessions that have been coerced sometimes form the basis of guilty verdicts, death sentences and executions. Competent legal assistance is unavailable to many defendants, including defendants facing drugs-related charges, leaving many with little capacity to mount a defense at any stage of the proceedings.
Draconian penalties for drug offenses, including the death penalty, hinder public health programs that reduce the harm drugs may cause to individual drug users, their loved ones, communities, and states. China, Malaysia, and Vietnam have recently stepped up their harm reduction programs to reduce HIV, hepatitis C and other drug-related health and social harms. However, excessive punishments and overly repressive drug law enforcement have been shown time and again to drive target groups away from such services. The death penalty therefore not only violates the right to life of those condemned, but is actually counterproductive to efforts to reduce the harm caused by drugs.
On the occasion of UN Anti-Drugs Day 2009, ADPAN, Amnesty International, Human Rights Watch and the IHRA appeal to Asian governments to:
Human Rights Watch is one of the world's leading independent organizations dedicated to defending and protecting human rights. By focusing international attention where human rights are violated, we give voice to the oppressed and hold oppressors accountable for their crimes. Our rigorous, objective investigations and strategic, targeted advocacy build intense pressure for action and raise the cost of human rights abuse. For 30 years, Human Rights Watch has worked tenaciously to lay the legal and moral groundwork for deep-rooted change and has fought to bring greater justice and security to people around the world.
"This administration’s failure to investigate or even acknowledge that these indiscriminate immigration raids are canceling the rights of US citizens is dangerous."
Days after new reporting revealed that at least 170 US citizens are among those who have been detained by federal immigration agents under the Trump administration, which Congresswoman Pramila Jayapal called "absolutely shocking," the Washington Democrat joined Rep. Jamie Raskin in demanding answers from top homeland security officials on the report.
Jayapal and Raskin (D-Md.) noted that they previously wrote to Homeland Security Secretary Kristi Noem and acting Immigration and Customs Enforcement (ICE) Director Todd Lyons in February, just weeks into President Donald Trump's second term, when the detention of US citizens ensnared in Trump's mass deportation operation was already raising alarm.
At that point, NBC News had reported on the detentions of US citizens including Native tribe members, which raised concerns about racial profiling—but in their Monday letter to Noem and Lyons, Jayapal and Raskin said the response they got in February was "flippant and unserious," with the officials simply reiterating existing policies that prohibit ICE from detaining US citizens—"without providing any assurance" that agents were "actually following that policy."
"This administration cannot hide behind a broad policy statement, as it continues to unlawfully detain US citizens as part of indiscriminate immigration raids," wrote Jayapal and Raskin.
The lawmakers emphasized that numerous arrests of US citizens by ICE and other immigration agents have been violent.
Raskin and Jayapal drew attention to four specific cases, including those of:
Other cases not mentioned in the letter include those of Job Garcia, a photographer who was tackled and held on the ground by ICE agents during a raid at a Home Depot in Los Angeles and then detained for more than 24 hours, and Debbie Brockman, a news producer in Chicago who was handcuffed by agents who accused her of throwing an object at them, and then hauled into an unmarked vehicle that crashed into another car as it sped away—only to be released later that day with no charges.
Raskin and Jayapal accused Noem and Lyons of overseeing a "lawless 'detain first, ask questions later' approach to immigration
enforcement" that is "terrorizing communities across the country."
"Masked, armed agents are snatching people on the street and refusing to identify themselves," said the lawmakers. "US citizens are now afraid to speak Spanish in public and are carrying their passports everywhere they go. This administration’s failure to investigate or even acknowledge that these indiscriminate immigration raids are canceling the rights of US citizens is dangerous."
Jayapal and Raskin demanded that Noem and Lyons provide an accounting of all the US citizens who have been detained with their identities, the length of time they were held, and their criminal records if they had any—which, according to an analysis by the CATO Institute in June, a majority of people arrested by ICE this year have not.
"We once again demand that you immediately provide a full accounting of all cases in which US citizens have been detained since January 20, 2025," said the Democrats, "and explain any concrete steps your agencies are implementing to prevent such abuses from continuing."
"Donald Trump and Republicans are selling out America's seniors," said one advocate.
A major pharmaceutical industry handout that Republicans—with the support of one Senate Democrat—included in President Donald Trump's signature legislative package is expected to cost US taxpayers nearly twice as much as originally expected, the nonpartisan Congressional Budget Office said in an updated analysis released Monday.
The CBO initially projected that the provision, known as the ORPHAN Cures Act, would cost around $5 billion over the next decade. But the office said Monday that its earlier assessment did not take into account several major, high-priced drugs that will be exempted from Medicare price negotiations as a result of the Trump-GOP law.
The budget office said it now expects the provision of Trump's One Big Beautiful Bill Act to cost $8.8 billion over the next 10 years.
Among the drugs included in the new CBO analysis is Keytruda, a cancer medication sold by Merck that carries a list price of $24,062 every six weeks. The Trump GOP-budget law delays Keytruda's eligibility for Medicare price negotiations by at least a year, postponing significant potential savings for taxpayers and patients.
Merith Basey, executive director of Patients for Affordable Drugs Now, said in response to the updated CBO analysis that "the ORPHAN Cures Act is a wildly expensive handout to Big Pharma that will harm patients, drain taxpayer dollars, and weaken the government's ability to rein in high drug prices."
Basey noted that the "insatiable" pharmaceutical industry is not satisfied with the enactment of the ORPHAN Cures Act, which restricts Medicare price negotiations for drugs that treat more than one rare disease. Big Pharma, Basey said, is "spending record sums this year to advance additional carveouts like the EPIC Act, which would exempt even more blockbuster drugs from negotiation."
"Any support for these bills goes against the will of the 90% of Americans who want Congress to go further to lower drug prices—not facilitate another handout to Big Pharma," said Basey.
"This isn't about helping lower costs—it's about doing the bidding of big drug companies, and Trump and the GOP are all too happy to oblige."
The deep-pocketed pharmaceutical industry has waged war on the popular Medicare price negotiation program since its inception during the Biden administration.
While pharmaceutical giants' efforts to gut the program have been stymied in court, the industry-friendly Trump administration and Republican lawmakers have done pharma's bidding through legislation and executive action. Earlier this year, as Common Dreams reported, Trump signed an executive order aimed at delaying price negotiations for a broad category of medications despite the president's repeated promises to bring down costs.
"Trump and Republicans are selling out America's seniors," said Brad Woodhouse, president of the advocacy group Protect Our Care. "Instead of letting Medicare negotiate lower prices for more drugs, they carved out a loophole to protect the industry's most profitable drugs."
"Not only does the GOP tax bill throw over 15 million Americans off their healthcare and hike costs for millions more, but it also forces older Americans to pay more for life-saving medicines while CEOs and billionaires line their pockets with more money than they know what to do with," Woodhouse continued. "This isn't about helping lower costs—it's about doing the bidding of big drug companies, and Trump and the GOP are all too happy to oblige."
Steve Knievel, access to medicines advocate at Public Citizen, said Monday that "instead of transferring $10 billion from taxpayers and cancer patients to drug corporations that are already extremely profitable, President Trump and members of Congress must work to strengthen and expand Medicare drug price negotiations."
"Instead of gutting the law through bills like the ORPHAN Cures Act, EPIC Act, and MINI Act so Big Pharma can block negotiations on blockbuster treatments," Knievel added, "Congress should pass legislation to empower Medicare to negotiate lower drug prices on all costly medicines and allow all patients to access lower, negotiated prices, even if they don't have Medicare."
"Healthcare costs are skyrocketing and federal workers aren’t getting paid. What is Trump doing? Building his gold plated ballroom."
A demolition crew on Monday began tearing down the East Wing facade of the White House in order to make way for President Donald Trump's luxury ballroom, in a project that one journalist said "captures" the president's approach to leading the country.
As reported by The Washington Post, workers used a backhoe to rip down the facade, and Trump later described the destruction as the start of a "much-needed project" at the White House.
“For more than 150 years, every president has dreamt about having a ballroom at the White House to accommodate people for grand parties, state visits, etc.,” Trump wrote on his Truth Social platform, without citing any evidence that "every president" has wanted such a ballroom.
The cost of the ballroom is estimated at $250 million, and Trump is financing it by soliciting donations from some of America's wealthiest corporations—including several with government contracts and interests in deregulation—such as Apple, Lockheed Martin, Microsoft, Meta, Google, Amazon, and Palantir. The president held an exclusive White House dinner for some of the largest donors to the ballroom last week, in a move that many critics decried as a "cash-for-access" event.
This is Trump’s presidency in a single photo: Illegal, destructive, and not helping you. pic.twitter.com/KOqk4mADpE
— Elizabeth Warren (@ewarren) October 21, 2025
The destruction of the East Wing facade comes as the federal government is three weeks into a shutdown that began when Democrats refused to join Republicans in voting for a continuing resolution that would allow crucial healthcare subsidies expire for millions of people, and Trump has shown little urgency in working to end the standoff—during which he's worked to purge the federal workforce.
Rep. Pramila Jayapal (D-Wash.) shredded Trump for working on a vanity project while government workers have been missing paychecks.
"We are 20 days into the Republican shutdown—healthcare costs are skyrocketing and federal workers aren’t getting paid," she wrote in a social media post. "What is Trump doing? Building his gold plated ballroom."
Sen. Elizabeth Warren (D-Mass.) also blasted Trump for focusing on his ballroom instead of on the needs of the American people.
"Oh, you're trying to say the cost of living is skyrocketing?" she asked rhetorically. "Donald Trump can't hear you over the sound of bulldozers demolishing a wing of the White House to build a new grand ballroom."
Former US Labor Secretary Robert Reich also linked Trump's focus on the ballroom to his lack of urgency in reopening the government.
"Trump hosted a dinner last week for donors helping fund his ballroom project," he wrote Monday. "Today, crews are starting construction and literally tearing down parts of the White House. It's day 20 of the government shutdown and this is what he's prioritizing?"
Sen. Andy Kim (D-NJ) shared an old photo of his family at the White House East Wing before it was torn down and expressed sadness about the president's destruction of the historic building.
"We didn’t need a billionaire-funded ballroom to celebrate America," he said. "Disgusting what Trump is doing."
Prem Thakker, a reporter for Zeteo, added that the destruction of the East Wing was highly symbolic of what the president is doing to the country.
"Trump demolishing the White House to build a $250 million ballroom funded by Amazon, Lockheed Martin, and Palantir," he wrote. "All during a government shutdown, and as he covers up the Epstein files—captures it all pretty well doesn't it."